Tom Woiwode
InvestorManaging Director at Versant Ventures · Board director at Santa Ana Bio · Board director at Jengu Therapeutics, Inc. · Board director at Bright Peak Therapeutics
San Francisco, California
Writes $100K – $5M checks · typically $1.5M
Find your path to Tom
806 people in our graph share verified history with Tom — schools, employers, funds. One of them is your warm intro.
About
Tom Woiwode is a PhD medicinal chemist with operating experience as CBO/COO who led IPOs/M&A exits including CRISPR Therapeutics and co-founds companies early with academics like Jim Wilson (iECURE).
Contact· self-published, not guessed
Invests in
BiotechHealthtechMedical Devices
Board director at Santa Ana Bio
Intro paths
In turn, Tom can intro founders to Santa Ana Bio's investors below.
Santa Ana Bio's investors · 5
Co-founders at Santa Ana Bio
Board director at Jengu Therapeutics, Inc.
Intro paths
In turn, Tom can intro founders to Jengu Therapeutics, Inc.'s investors below.
Jengu Therapeutics, Inc.'s investors · 1
Board director at Bright Peak Therapeutics
Intro paths
In turn, Tom can intro founders to Bright Peak Therapeutics's investors below.
Bright Peak Therapeutics's investors · 9
Co-founders at Bright Peak Therapeutics
Experience
- Versant VenturesManaging Directorcurrent2014 — present
- Versant VenturesVenture Partner2005 — 2014
- Versant VenturesAssociate/Principal2002 — 2005
- OkairosChief Operating Officer2011 — 2013
- FlexionChief Business Officer2008 — 2010
- SynosiaChief Business Officer2006 — 2008
- AmiraChief Business Officer2005 — 2006
- XenoPortResearch Scientist2000 — 2002
Deals · 1
Bright Peak TherapeuticsBoard seat
via Versant Ventures · filed Jun 2024 · $90M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Investor
AnokionAudentes TherapeuticsBelharra TherapeuticsCrinetics PharmaceuticalsCRISPR TherapeuticsGritstone BioIecurePassage BioSaegis PharmaceuticalsTempest TherapeuticsTherachonVectivBioVividion Therapeutics
Sources: SEC Form D filings · curated public sources.
Colleagues at Versant Ventures
Frequently asked questions
- Who is Tom Woiwode?
- Tom Woiwode is a PhD medicinal chemist with operating experience as CBO/COO who led IPOs/M&A exits including CRISPR Therapeutics and co-founds companies early with academics like Jim Wilson (iECURE).
- Where does Tom Woiwode work?
- Tom Woiwode is Managing Director at Versant Ventures and Board director at Santa Ana Bio and Board director at Jengu Therapeutics, Inc. and Board director at Bright Peak Therapeutics.
- What does Tom Woiwode invest in?
- Tom Woiwode invests in Biotech, Healthtech, Medical Devices.
- What check size does Tom Woiwode write?
- Tom Woiwode typically writes checks of $100K – $5M.
- What boards does Tom Woiwode sit on?
- Tom Woiwode holds tracked board seats at Bright Peak Therapeutics.
- What companies has Tom Woiwode invested in?
- Investments tracked here include Anokion, Audentes Therapeutics, Belharra Therapeutics, Bright Peak Therapeutics, Crinetics Pharmaceuticals, CRISPR Therapeutics, Gritstone Bio, Iecure, Passage Bio, Saegis Pharmaceuticals, Tempest Therapeutics, Therachon, and 2 more.
- Where did Tom Woiwode go to school?
- Tom Woiwode studied at Stanford University (PhD, Chemistry); University of California, Berkeley (BS, Chemistry).
Same school
Also attended Stanford University2,000
+ 1,994 more
Also attended University of California, Berkeley2,000
+ 1,994 more
Shared employers
Also worked at Versant Ventures43
+ 37 more
